The advantages and disadvantages of a 'herbal' medicine in a patient with a diabetes mellitus: A case report

Diabetic Medicine

Volumn 21, Issue 6, 2004, Pages 625-627

  Wood, D M ^a   Athwal, S ^b   Panahloo, A ^c  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Alternative medicine; Chlorpropamide; Diabetes mellitus

Indexed keywords

CHLORPROPAMIDE; GLICLAZIDE; HEMOGLOBIN A1C; INSULIN; METFORMIN;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DIABETIC ANGIOPATHY; DIABETIC MICROANGIOPATHY; DIABETIC OBESITY; DIABETIC RETINOPATHY; FAMILY HISTORY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISCHEMIC HEART DISEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; ULTRAVIOLET RADIATION; VITREOUS HEMORRHAGE;

CHLORPROPAMIDE; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT PREPARATIONS; TREATMENT OUTCOME;

EID: 2942547274     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01202.x     Document Type: Article

References (15)

1. Ong C-K, Petersen S, Bodeker GC, Stewart-Brown S. Health status of people using complementary and alternative medical practioner services in 4 English counties. Am J Public Health 2002; 92: 1653-6.
2. Shenfield GM, Boutagy JS, Webb C. A screening test for detecting sulfonylureas in plasma. Therapeutic Drug Monitoring 1990; 12: 393-397.
3. Shenfield GM, Logan A, Shirling D, Baird J. Plasma insulin and glucose levels in maturity onset diabetes treated with chlorpropamide. Diabetologia 1977; 13: 367-371.
4. Setlzer HS. Drug-induced hypoglycaemia. Diabetes 1972; 21: 955-966.
5. Weissman PN, Shenkman L, Gregerman RI. Chlorpropamide hyponatraemia, drug-induced inappropriate anti-diuretic hormone activity. N Eng J Med 1971; 284: 65-71.
6. British National Formulary. Sulphonylureas. British National Formulary 2002; 44: Section 6.1.2.1.
7. Cronin AJ, Maidment G, Cook T, Kite GC, Simmonds MS, Pusey CD et al. Aristolochic acid as a causative factor in a case of Chinese herbal nephropathy. Nephrol Dial Transplant 2002; 17: 524-5.
8. Ries CA, Sahud MA. Agranulocytosis caused by Chinese herbal medicines. Dangers of medications containing aminopyrine and phenylbutazone. JAMA 1975; 231: 352-5.
9. Shaw D, Leon C, Kolev S, Murray V. Traditional remedies and food supplements. A 5-year toxicological study (1991-95). Drug Safety 1997; 17: 342-356.
10. Ernst E. Toxic heavy metals and undeclared drugs in Asian herbal medicines. Trends Pharmacol Sci 2002; 23: 136-9.
11. Goudie AM, Kaye JM. Contaminated medication precipitating hypoglycaemia. MJA 2001; 175: 256-257.
12. Huang WF, Wen K-C, Hsiao M-L. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol 1997; 37: 344-350.
13. Koh H-W, Woo S-O. Chinese proprietary medicine in Singapore. Regulatory control of toxic heavy metals and undeclared drugs. Drug Safety 2000; 23: 351-362.
14. Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998; 158: 2200-2211.
15. Ryan EA, Pick ME, Marceau C. Use of alternative medicines in diabetes mellitus. Diabet Med 2001; 18: 242-245.